News

Press Releases and Publications

Duo Oncology Announces Close of Initial Seed Investment

​

Duo Oncology is pleased to announce a $1M+ seed investment led by UPMC oncologists Dr. Stanley Marks and Dr. Jing-Zhou Hou.

Duo Oncology Joins LifeX Incubator

​

LifeX Labs welcomes new portfolio company, Duo Onoclogy, into incubator program.

Duo Oncology Appoints Dr. Stanley Marks to Board of Directors

​

Duo Oncology is pleased to welcome Dr. Stanley Marks to its board of directors. Dr. Marks is a world renown oncology and chairman of the UPMC Hillman Cancer Center.

Duo Oncology Options Nanoparticle Platform from University of Pittsburgh

​

Duo Oncology signed an option to exclusively license nanoparticle prodrug chemistry patented developed in the laboratory of Dr. Song Li and patented by the University of Pittsburgh

©2020 by Duo Oncology, Pittsburgh PA.

  • Twitter
  • LinkedIn